Piramal Pharma Ltd Half Yearly Results

Gross Sales

4,958.29

4,192.89

4,510.93

3,660.23

3,879.55

Excise Duty

0

0

0

0

0

Net Sales

4,958.29

4,192.89

4,510.93

3,660.23

3,879.55

Other Operating Income

0

0

0

0

0

Other Income

87.43

120.31

113.88

121

130.39

Total Income

5,045.72

4,313.2

4,624.81

3,781.23

4,009.94

Total Expenditure

4,059.56

3,646.79

3,775.42

3,262.27

3,440.95

PBIDT

986.16

666.41

849.39

518.96

568.99

Interest

206.99

214.6

220.1

228.39

198.9

PBDT

779.17

451.81

629.29

290.57

370.09

Depreciation

439.57

376.77

382.45

358.12

348.84

Minority Interest Before NP

0

0

0

0

0

Tax

165.79

144.33

134.3

51.05

58.83

Deferred Tax

16.63

-3.24

1.16

-25.04

2.49

Reported Profit After Tax

157.18

-66.05

111.38

-93.56

-40.07

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

157.18

-66.05

111.38

-93.56

-40.07

Extra-ordinary Items

0

0

-62.79

0

0

Adjusted Profit After Extra-ordinary item

157.18

-66.05

174.17

-93.56

-40.07

EPS (Unit Curr.)

1.19

-0.5

0.84

-0.75

0

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

1,324.35

1,323.14

1,322.95

1,322.95

1,193.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.88

15.89

18.82

14.17

14.66

PBDTM(%)

-

-

-

-

-

PATM(%)

3.17

-1.57

2.46

-2.55

-1.03